Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2
Introduction 9
2.1 What Is This Report About? 9
3 Definitions of
Markets Covered in the Report 10
3.1 Diabetic Care Devices 10
3.2
Glucose Monitoring Devices 10
3.2.1 Blood Glucose Meters 10
3.2.2
Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Pens
10
3.3.2 Insulin Syringes 11
3.3.3 Insulin Pumps 11
3.3.4
Traditional Insulin Pump Accessories 11
4 Healthcare Sector Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure 16
4.3
Healthcare Policy 20
4.4 Canada Healthcare Trade Statistics 21
5
Regulation System 22
5.1 Medical Equipment Approval Process 22
5.1.1
Classification 22
5.1.2 Conformity Assessment 23
5.1.3 License Fee
25
5.1.4 License Application Processing Duration 25
5.2 Labeling and
Packaging 25
5.3 Post-Market Surveillance 26
6 Pricing and
Reimbursement 27
7 Distribution Structure 29
7.1 Distribution
Structure 29
8 Diabetes Care Devices In Canada 30
8.1 Diabetes Care
Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 30
8.2
Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
8.3
Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015 35
8.4
Diabetes Care Devices, Canada, Company Share (2007-2008) 38
9 Glucose
Monitoring In Canada 39
9.1 Glucose Monitoring Overall Revenue (2000-2015)
39
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 40
9.2
Glucose Monitoring Overall Volume (2000-2015) 42
9.2.1 Blood Glucose
Meters Overall Volume (2000-2015) 43
9.3 Glucose Monitoring Average Price
(2000-2015) 45
9.4 Glucose Monitoring Distribution Share (2007-2008)
46
9.5 Glucose Monitoring, Canada, Company Share (2007-2008) 47
10
Insulin Delivery In Canada 48
10.1 Insulin Delivery Overall Revenue
(2000-2015) 48
10.1.1 Insulin Pens Overall Revenue (2000-2015) 50
10.2
Insulin Delivery Overall Volume (2000-2015) 52
10.2.1 Insulin Pens Overall
Volume (2000-2015) 53
10.3 Insulin Delivery Average Price (2000-2015)
55
10.4 Insulin Delivery Distribution Share (2007-2008) 56
10.5
Insulin Delivery, Canada, Company Share (2007-2008) 57
11 Overview of Key
Companies in Canada Diabetes Care Devices Market 58
11.1 F. Hoffmann-La
Roche Ltd. 58
11.1.1 Company Overview 58
11.1.2 Value Chain Analysis
59
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 61
11.2 Bayer
HealthCare AG 62
11.2.1 Company Overview 62
11.2.2 Value Chain
Analysis 63
11.2.3 Bayer HealthCare AG Pipeline Products 65
11.3
LifeScan, Inc. 66
11.3.1 Company Overview 66
11.3.2 LifeScan, Inc.
Pipeline Products 66
11.4 Abbott Laboratories 68
11.4.1 Company
Overview 68
11.4.2 Value Chain Analysis 69
11.4.3 Abbott Laboratories
Pipeline Products 71
11.5 Novo Nordisk A/S 73
11.5.1 Company Overview
73
11.5.2 Novo Nordisk A/S Pipeline Products 73
11.6 Sanofi-Aventis
75
11.6.1 Company Overview 75
11.7 Medtronic, Inc. 76
11.7.1
Company Overview 76
11.7.2 Value Chain Analysis 77
11.7.3 Medtronic,
Inc. Pipeline Products 79
11.8 Terumo Corporation 87
11.8.1 Company
Overview 87
11.8.2 Value Chain Analysis 87
11.9 Apex Biotechnology
Corp. 90
11.9.1 Company Overview 90
11.10 Becton, Dickinson and
Company 91
11.10.1 Company Overview 91
11.10.2 Value Chain Analysis
91
11.11 Eli Lilly and Company 93
11.11.1 Company Overview 93
11.11.2 Value Chain Analysis 93
11.11.3 Eli Lilly and Company Pipeline
Products 96
11.12 Animas Corporation 97
11.12.1 Company Overview
97
11.13 Smiths Medical 98
11.13.1 Company Overview 98
11.13.2
Value Chain Analysis 99
11.14 Glucoplus Inc. 101
11.14.1 Company
Overview 101
12 Appendix 102
12.1 Global Markets Direct Research
Methodology 102
12.2 Coverage 103
12.3 Secondary Research 103
12.4
Primary Research 104
12.5 Models 104
12.6 Forecasts 105
12.7
Expert Panel Validation 105
12.8 Currency Conversion 106
12.9 Contact
Us 107
12.10 Disclaimer 107
1.1 List of Tables
Table 1:
Healthcare Expenditure, Canada, 2000-2007 15
Table 2: Number of Physicians
by Province in Canada, 2001 and 2005 16
Table 3: Number of Physicians by
Province in Canada, 2001 and 2007 17
Table 4: Hospital Wards by Specialty
in Canada, 2003-2007 18
Table 5: Doctors by Specialty in Canada, 2003-2007
19
Table 6: Canada Healthcare Trade Statistics, 2001-2006 21
Table 7:
Medical Equipment Classification in Canada, 2007 22
Table 8: Medical
Equipment Licensing Fee in Canada, 2007 25
Table 9: Medical Equipment
License Processing Duration in Canada, 2007 25
Table 10: Private
Reimbursement Providers, Canada 28
Table 11: Diabetes Care Devices,
Cross Country Comparison, Revenue ($ mn), 2000-2015 30
Table 12:
Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
Table
13: Diabetes Care Devices, Canada, Cross-Category Analysis, 2000-2015 32
Table 14: Diabetes Care Devices, Canada, Overall Revenue ($ mn),
Historic, 2000-2008 33
Table 15: Diabetes Care Devices, Canada,
Overall Revenue ($ mn), Forecast, 2008-2015 34
Table 16: Diabetes
Care Devices, Canada, Category Volume (Units), 2000-2015 35
Table 17:
Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2008
36
Table 18: Diabetes Care Devices, Canada, Category Volume (Units),
Forecast, 2008-2015 37
Table 19: Diabetes Care Devices, Canada,
Company Share by Revenue ($ mn), 2007-2008 38
Table 20: Glucose
Monitoring, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 39
Table 21: Glucose Monitoring, Canada, Revenue ($ mn) by Segment,
Forecast, 2008-2015 39
Table 22: Blood Glucose Meters, Canada,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 40
Table 23: Blood
Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
41
Table 24: Glucose Monitoring, Canada, Volume (Units) by Segment,
Historic, 2000-2008 42
Table 25: Glucose Monitoring, Canada, Volume
(Units) by Segment, Forecast, 2008-2015 42
Table 26: Blood Glucose
Meters, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 43
Table 27: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 44
Table 28: Glucose Monitoring, Canada, Average
Price ($), Historic, 2000-2008 45
Table 29: Glucose Monitoring,
Canada, Average Price ($), Forecast, 2008-2015 45
Table 30: Glucose
Monitoring, Canada, Distribution Share by Revenue ($mn), 2007-2008 46
Table 31: Glucose Monitoring, Canada, Company Share by Revenue ($ mn),
2007-2008 47
Table 32: Insulin Delivery, Canada, Revenue ($ mn) by
Segment, Historic, 2000-2008 48
Table 33: Insulin Delivery, Canada,
Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 34: Insulin
Pens, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Table
35: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 51
Table 36: Insulin Delivery, Canada, Volume (Units) by
Segment, Historic, 2000-2008 52
Table 37: Insulin Delivery, Canada,
Volume (Units) by Segment, Forecast, 2008-2015 52
Table 38: Insulin
Pens, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 53
Table
39: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Forecast,
2008-2015 54
Table 40: Insulin Delivery, Canada, Average Price ($),
Historic, 2000-2008 55
Table 41: Insulin Delivery, Canada, Average
Price ($), Forecast, 2008-2015 55
Table 42: Insulin Delivery, Canada,
Distribution Share by Revenue ($mn), 2007-2008 56
Table 43: Insulin
Delivery, Canada, Company Share by Revenue ($ mn), 2007-2008 57
Table 44:
F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 61
Table
45: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
61
Table 46: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy
Area 61
Table 47: Bayer HealthCare AG Pipeline Products by Equipment
Type 65
Table 48: Bayer HealthCare AG Pipeline Products by
Development Stage 65
Table 49: Bayer HealthCare AG Pipeline Products
by Therapy Area 65
Table 50: Bayer HealthCare AG Pipeline Products by
News Summary 65
Table 51: LifeScan, Inc. Pipeline Products by
Equipment Type 66
Table 52: LifeScan, Inc. Pipeline Products by
Development Stage 66
Table 53: LifeScan, Inc. Pipeline Products by
Therapy Area 66
Table 54: LifeScan, Inc. Pipeline Products by
Clinical Trials 67
Table 55: LifeScan, Inc. Pipeline Products by News
Summary 67
Table 56: Abbott Laboratories Pipeline Products by
Equipment Type 71
Table 57: Abbott Laboratories Pipeline Products by
Development Stage 71
Table 58: Abbott Laboratories Pipeline Products
by Therapy Area 71
Table 59: Abbott Laboratories Pipeline Products
by Clinical Trials 72
Table 60: Abbott Laboratories Pipeline
Products by News Summary 72
Table 61: Novo Nordisk A/S Pipeline
Products by Equipment Type 73
Table 62: Novo Nordisk A/S Pipeline
Products By Development Stage 73
Table 63: Novo Nordisk A/S Pipeline
Products By Therapy Area 73
Table 64: Novo Nordisk A/S Pipeline
Products By Clinical Trials 74
Table 65: Medtronic, Inc. Pipeline
Products by Equipment Type 79
Table 66: Medtronic, Inc. Pipeline
Products By Development Stage 81
Table 67: Medtronic, Inc. Pipeline
Products By Therapy Area 83
Table 68: Medtronic, Inc. Pipeline
Products By Clinical Trials 85
Table 69: Medtronic, Inc. Pipeline
Products By News Summary 86
Table 70: Eli Lilly and Company Pipeline
Products by Equipment Type 96
Table 71: Eli Lilly and Company
Pipeline Products by Development Stage 96
Table 72: Eli Lilly and
Company Pipeline Products by Therapy Area 96
Table 73: Eli Lilly and
Company Pipeline Products by Clinical Trials 96
Table 74: Eli Lilly
and Company Pipeline Products by News Summary 96
Table 75: USD to Local
Currency, Average Exchange Rate 2008 106
1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004 13
Figure 2: Healthcare
Expenditure, Canada, 2000 - 2007 14
Figure 3: Diabetes Care Devices,
Cross Country Comparison, Revenue ($ mn), 2000-2015 30
Figure 4:
Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
Figure
5: Diabetes Care Devices, Canada, Cross-Category Analysis, 2000-2015
32
Figure 6: Diabetes Care Devices, Canada, Overall Revenue ($ mn),
Historic, 2000-2008 33
Figure 7: Diabetes Care Devices, Canada,
Overall Revenue ($ mn), Forecast, 2008-2015 34
Figure 8: Diabetes
Care Devices, Canada, Category Volume (Units), 2000-2015 35
Figure 9:
Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2008
36
Figure 10: Diabetes Care Devices, Canada, Category Volume (Units),
Forecast, 2008-2015 37
Figure 11: Diabetes Care Devices, Canada,
Company Share (%), 2008 38
Figure 12: Blood Glucose Meters, Canada,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 40
Figure 13:
Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 41
Figure 14: Blood Glucose Meters, Canada, Volume (Units)
by Sub-Segment, Historic, 2000-2008 43
Figure 15: Blood Glucose
Meters, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 44
Figure 16: Glucose Monitoring, Canada, Company Share (%), 2008 47
Figure 17: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Historic,
2000-2008 48
Figure 18: Insulin Delivery, Canada, Revenue ($ mn) by
Segment, Forecast, 2008-2015 49
Figure 19: Insulin Pens, Canada,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Figure 20:
Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
51
Figure 21: Insulin Pens, Canada, Volume (Units) by Sub-Segment,
Historic, 2000-2008 53
Figure 22: Insulin Pens, Canada, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 54
Figure 23: Insulin
Delivery, Canada, Company Share (%), 2008 57
Figure 24: F.
Hoffmann-La Roche Ltd Value Chain Analysis 59
Figure 25: Bayer
HealthCare AG Value Chain Analysis 63
Figure 26: Abbott Laboratories
Value Chain Analysis 69
Figure 27: Medtronic, Inc. Value Chain
Analysis 77
Figure 28: Terumo Corporation Value Chain Analysis 87
Figure 29: Becton, Dickinson and Company Value Chain Analysis 91
Figure 30: Eli Lilly and Company Value Chain Analysis 93
Figure 31:
Smiths Medical Value Chain Analysis 99
Figure 32: Global Markets
Direct Methodology 102
|
Related Report
|
View Cart
